SALA / ROOM LOS PRECURSORES

Sexta-feira 30 de novembro 16:15 - 18:25 hs.

16:15

O52 New Diagnostic Validation Test of Testosterone Deficiency Sindrome-Potenziani 2007

Potenziani, JC; Potenziani, SD

Ver resumo

16:25

O53 A randomised, double-blind comparison of vardenafil and sildenafil: efficacy in men with erectile dysfunction and cardiovascular risk factors

Rubio-Aurioles, E; Porst, H; Eardley, I; Goldstein, I

Ver resumo

16:35

O54 Erectile dysfunction assessed by females: development and validation of the Female Assessment of Male Erectile dysfunction detection scale (FAME)

Rubio-Aurioles, E; Arango de Montis, I; Terrein Roccatti, N; Sand, M

Ver resumo

16:45

O55 PREVALENCIA DE INSULINORRESISTENCIA (IR) Y COMPROMISO VASCULAR (CV) EN PACIENTES CON DISFUNCION ERECTIL (DE).

Rey Valzacchi, G; Costanzo, P; Gueglio, G; Layus, O; Finger, L; Knoblovits, P

Ver resumo

16:55

O56 EVALUACIÓN DE SINDROME METABOLICO (SM)Y TOLERANCIA ALTERADA A LOS HIDRATOS DE CARBONO (TAG) EN HOMBRES CON DISFUNCIÓN ERÉCTIL (DE).

Costanzo, P; Knoblovits, P; Rey Valzacchi, G; Layus, O; Finger, L; Gueglio, G

Ver resumo

17:05

O57 Erectile dysfunction severity is associated with increased circulating concentrations of Interleukin-6 and soluble E-selectin in patients with type-2 diabetes mellitus.

Araña Rosaínz, MJ; Fragas Valdés, R; Estevez Baez, M; Garcia Alvarez, CT; Orlandi Gonzalez, N

Ver resumo

17:15

O59 High Plasma Levels of Dihydrotestosterone Decline in Hypogonadal Men Following Testosterone Substitution

Gooren, L; Saad, F; Haider, A; Yassin, A

Ver resumo

17:25

O60 Testosterone Treatment With Long-Acting Testosterone Undecanoate in Men with Late-Onset Hypogonadism and the Metabolic Syndrome Reduced Serum Levels of Interleukin-6, Tumor Necrosis Factor alpha and C-Reactive Protein

Tishova, Y; Mskhalaya, G; Saad, F; Kalinchenko, S

Ver resumo

17:35

O61 Evaluación endócrina en disfunción sexual masculina de acuerdo a la medicina basada en la evidencia

Terradas, C; Nagelberg, A; Subcomite de Sexualidad Masculina, S

Ver resumo

17:45

O62 15 Months of Treatment with Long Acting Testosterone Undecanoate (Nebido) Improves Features of the Metabolic Syndrome

Saad, F; Gooren, L; Haider, A; Yassin, A

Ver resumo

17:55

O63 Efficacy and Safety of Long-Acting Testosterone Undecanoate Over 4 Years

Freude, S; Huebler, D; Schubert, M; Gooren, L; Jockenhoevel, F; Saad, F

Ver resumo

18:05

O64 HIPERPLASIA PROSTÁTICA BENIGNA SINTOMÁTICA: FACTOR DE RIESGO PARA DISFUNCIÓN SEXUAL

Salirrosas Ponce, MJ; Salirrosas Bermúdez, SV

Ver resumo